Alkermes
ALKS
$24.65
Share price
1.61%
Change (1 day)
-15.52%
Change (1 year)
Categories
Operating Margin for Alkermes (ALKS)
Operating Margin as of April 2024 (TTM): -15.04%
According to Alkermes's latest financial reports and stock price the company's current Operating Margin is -15.04%. At the end of 2022 the company had an Operating Margin of -15.05%.
Operating Margin history for Alkermes from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -15.05% | 349.36% |
| 2021 | -3.35% | -63.97% |
| 2020 | -9.29% | -44.78% |
| 2019 | -16.83% | 45.04% |
| 2018 | -11.60% | -26.84% |
| 2017 | -15.86% | -44.84% |
| 2016 | -28.75% | -19.36% |
| 2015 | -35.65% | 1472.47% |
| 2014 | -2.27% | -136.82% |
| 2013 | 6.16% | -120.99% |
| 2012 | -29.33% | 17.76% |
| 2011 | -24.91% | -0.65% |
| 2010 | -25.07% | -162.55% |
| 2009 | 40.08% | -44.17% |
| 2008 | 71.80% | 1534.17% |
| 2007 | 4.39% | -46.42% |
| 2006 | 8.20% | -110.3% |
| 2005 | -79.60% | -67.99% |
| 2004 | -248.65% | 9.95% |
| 2003 | -226.16% | 99.42% |
| 2002 | -113.41% | 276.67% |
| 2001 | -30.11% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -252.13% | 🇺🇸 USA |
 Novartis NVS | 17.27% | -214.83% | 🇨🇭 Switzerland |
 Pfizer PFE | 34.61% | -330.12% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -221.08% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | 19.24% | -227.93% | 🇺🇸 USA |
 AstraZeneca AZN | 5.63% | -137.43% | 🇬🇧 UK |
 Zogenix ZGNX | -259.55% | 1,625.74% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -84.50% | 461.84% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -20.53% | 36.50% | 🇮🇱 Israel |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.